Phase 1 Carcinoid Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Not Yet Recruiting

Phase 1

A Phase 1, Single-Dose, Open-Label, Randomized, Three-Period, Two-Sequence, Crossover Study to Evaluate the Relative Bioavailability of Paltusotine Low Drug Load (LDL) Tablets 60 mg (2 × 30 mg LDL tablet) and High Drug Load (HDL) Tablet 60 mg (1 × 60 mg HDL tablet) in Healthy Volunteers.

Carcinoid SyndromeAcromegaly

Crinetics Pharmaceuticals, Inc20 enrolled1 locationACTRN12625001148460

Recruiting

Phase 1Phase 2

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

NeoplasmsNeoplasm MetastasisMetastatic Gastrointestinal Carcinoid Tumor

Shanghai EpimAb Biotherapeutics Co., Ltd.152 enrolled14 locationsNCT05176665